You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
30 November 2023
HAEMATO AG: Termination of listing in the Open Market
15 November 2023
Termination of the botulinum toxin project
3 May 2022
HAEMATO AG: Dividend of EUR 1.10
25 October 2021
HAEMATO seeks marketing authorization and plans distribution of a botulinum toxin product under its own brand in Europe
11 August 2021
HAEMATO AG announces preliminary figures for Q2 2021: Increase in Q2 revenue by 41% and EBIT by 596% compared to the same quarter last year.
4 May 2021
HAEMATO AG proposes dividend payment
